630 filings
Page 5 of 32
8-K
1a4d0xe qk
23 Jun 21
Termination of a Material Definitive Agreement
6:01am
DEFA14A
ew3h07g
17 Jun 21
Additional proxy soliciting materials
4:38pm
8-K
of3rvu8fl3k
16 Jun 21
United Therapeutics Announces Fda Acceptance
6:00am
8-K
n8zgci1g
7 Jun 21
Other Events
6:01am
8-K
eat8k8eq587 lpoeu
3 Jun 21
United Therapeutics Announces First Patient Enrolled In Phase 3 Teton Study of Tyvaso In Patients with Idiopathic Pulmonary Fibrosis
6:00am
SD
gb5p3ea
1 Jun 21
Conflict minerals disclosure
4:30pm
8-K
nqw7w
5 May 21
United Therapeutics Corporation Reports First Quarter 2021 Financial Results
6:17am
DEFA14A
6o26a3lnd20qono
29 Apr 21
Additional proxy soliciting materials
4:30pm
DEFA14A
6ahok dvdqxm30q
29 Apr 21
Additional proxy soliciting materials
6:07am
8-K
t72r j6t66hh7
19 Apr 21
United Therapeutics Announces Submission of Tyvaso Dpi™ New Drug Application to Fda
6:02am
8-K
qocuu c2v
1 Apr 21
Other Events
6:03am
8-K
3lz 05to3rd7cl3fu5j2
3 Mar 21
Other Events
6:02am
8-K
ocyyj6yh1 tc6rd
24 Feb 21
United Therapeutics Corporation Reports Fourth Quarter
6:09am
8-K
j6wt2i2nmrhb
10 Feb 21
United Therapeutics Announces Commercial Launch
6:01am
8-K
m1tyfb 8bb67
5 Feb 21
Amendments to Articles of Incorporation or Bylaws
6:05am
8-K
eychucdzi m9b
28 Jan 21
United Therapeutics Announces Breeze Study of
6:01am
8-K
yqysx3cihpf161d 9ps
22 Jan 21
Other Events
6:01am